France to expand access to weight-loss drugs for obesity patients
- Posted on May 28, 2026
- By Le Monde
- 1 Views
- 1 min read
France to expand access to weight-loss drugs for obesity patients
The obesity treatments Wegovy and Mounjaro will be covered starting in mid-June in France, under a controlled framework. This measure will cost the state an estimated €100 million annually.